X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (78715) 78715
Newsletter (28907) 28907
Newspaper Article (27894) 27894
Book Review (8933) 8933
Publication (5307) 5307
Magazine Article (1326) 1326
Trade Publication Article (1110) 1110
Web Resource (705) 705
Book Chapter (596) 596
Conference Proceeding (534) 534
Dissertation (295) 295
Transcript (192) 192
Book / eBook (104) 104
Streaming Video (53) 53
Reference (51) 51
Report (29) 29
Government Document (17) 17
Journal / eJournal (16) 16
Paper (12) 12
Data Set (10) 10
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (52674) 52674
papillomavirus infections (51764) 51764
human papillomavirus (50568) 50568
humans (49001) 49001
cervical cancer (39873) 39873
female (35904) 35904
cancer (30635) 30635
research (25648) 25648
vaccines (22141) 22141
adult (19725) 19725
middle aged (16928) 16928
male (16569) 16569
papillomaviruses (16379) 16379
oncology (16164) 16164
health aspects (15784) 15784
medical research (12777) 12777
immunization (11472) 11472
women (11416) 11416
aged (10766) 10766
risk factors (9571) 9571
womens health (9489) 9489
medicine, experimental (9451) 9451
infection (9102) 9102
animals (9051) 9051
adolescent (8815) 8815
oncology, experimental (8389) 8389
human-papillomavirus (8114) 8114
analysis (8054) 8054
papillomavirus infections - virology (7979) 7979
uterine cervical neoplasms - virology (7844) 7844
care and treatment (7653) 7653
vaccination (7402) 7402
squamous cell carcinoma (7259) 7259
papillomaviridae - genetics (7253) 7253
hpv (7243) 7243
dna (7142) 7142
diagnosis (6788) 6788
papillomaviridae - isolation & purification (6730) 6730
prevalence (6502) 6502
prevention (6458) 6458
universities and colleges (6453) 6453
infections (5894) 5894
reports (5770) 5770
papillomavirus infections - complications (5753) 5753
young adult (5709) 5709
genetic aspects (5623) 5623
medical screening (5595) 5595
pathology (5330) 5330
papillomavirus infections - epidemiology (5299) 5299
virology (5268) 5268
studies (5266) 5266
tumors (5185) 5185
papillomavirus infections - prevention & control (5184) 5184
abridged index medicus (5159) 5159
polymerase chain reaction (4919) 4919
immunology (4873) 4873
mice (4815) 4815
papillomavirus infections - diagnosis (4798) 4798
infectious diseases (4735) 4735
risk (4692) 4692
uterine cervical neoplasms - pathology (4649) 4649
obstetrics & gynecology (4597) 4597
epidemiology (4519) 4519
squamous-cell carcinoma (4424) 4424
cancer vaccines (4389) 4389
cervical-cancer (4188) 4188
prognosis (4183) 4183
uterine cervical neoplasms - prevention & control (4029) 4029
child (4025) 4025
carcinoma (3975) 3975
public health (3970) 3970
expression (3969) 3969
surgery (3922) 3922
proteins (3891) 3891
dna, viral - analysis (3868) 3868
papilloma - pathology (3853) 3853
carcinoma, squamous cell - pathology (3759) 3759
aged, 80 and over (3740) 3740
viruses (3639) 3639
carcinoma, squamous cell - virology (3537) 3537
uterine cervical neoplasms - diagnosis (3482) 3482
cervical intraepithelial neoplasia (3469) 3469
lesions (3451) 3451
immunohistochemistry (3414) 3414
papillomavirus infections - pathology (3410) 3410
papilloma (3391) 3391
sexually transmitted diseases (3318) 3318
development and progression (3314) 3314
public, environmental & occupational health (3245) 3245
deoxyribonucleic acid--dna (3240) 3240
cervical intraepithelial neoplasia - virology (3220) 3220
retrospective studies (3144) 3144
intraepithelial neoplasia (3142) 3142
article (3082) 3082
medicine, research & experimental (3080) 3080
human-papillomavirus infection (2953) 2953
cell biology (2943) 2943
genotype (2908) 2908
immunotherapy (2903) 2903
uterine cervical neoplasms - epidemiology (2845) 2845
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (71) 71
Gerstein Science - Stacks (51) 51
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
New College (Ivey) - Stacks (2) 2
Robarts - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Searching (1) 1
Robarts - Government Pubs (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
University Archives - Archives (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (134337) 134337
French (1157) 1157
Spanish (894) 894
German (792) 792
Russian (703) 703
Japanese (331) 331
Polish (331) 331
Chinese (271) 271
Portuguese (206) 206
Italian (165) 165
Korean (130) 130
Czech (121) 121
Hungarian (69) 69
Danish (58) 58
Bulgarian (53) 53
Turkish (39) 39
Dutch (38) 38
Croatian (36) 36
Swedish (27) 27
Serbian (22) 22
Hebrew (17) 17
Finnish (16) 16
Persian (15) 15
Romanian (13) 13
Slovak (13) 13
Lithuanian (11) 11
Ukrainian (10) 10
Bosnian (7) 7
Norwegian (6) 6
Slovenian (5) 5
Hindi (3) 3
Icelandic (3) 3
Afrikaans (2) 2
Arabic (2) 2
Estonian (2) 2
Greek (2) 2
Indonesian (1) 1
Latin (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent... 
Internal Medicine | WOMEN | POPULATION | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | VACCINE | HPV INFECTION | FOLLOW-UP | RISK | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age | Index Medicus | Abridged Index Medicus
Journal Article
2007, ISBN 0387365222, xix, 419
This volume will evaluate the carcinogenic risk to humans posed by infection with human papillomaviruses (HPVs). To date, more than 70 HPV types have been... 
Papillomaviruses | Papillomavirus vaccines | Papillomavirus diseases | Clinical & internal medicine | Infectious Diseases | Cancer Research | Biomedicine | Immunology | Microbiology | Virology
Book
Virology, ISSN 0042-6822, 2016, Volume 500, pp. 218 - 225
Abstract Human Papillomavirus E6 and E7 play critical roles in cancer development, although not all isolates of the viral oncoproteins are identical. A common... 
Infectious Disease | pRb | CKII phosphorylation | TBP | HPV | ONCOPROTEIN | PROTEIN | HUMAN-PAPILLOMAVIRUS TYPE-16 | SEQUENCE VARIATION | PHOSPHORYLATION | RETINOBLASTOMA TUMOR-SUPPRESSOR | 16 E6 | COMPLEX-FORMATION | VIROLOGY | ADENOVIRUS E1A | DEGRADATION | Phosphorylation | Human papillomavirus 16 - physiology | Humans | Retinoblastoma Protein - metabolism | Amino Acid Motifs | Papillomavirus E7 Proteins - genetics | Papillomavirus Infections - genetics | TATA-Box Binding Protein - metabolism | Papillomavirus E7 Proteins - metabolism | TATA-Box Binding Protein - genetics | Papillomavirus Infections - metabolism | Retinoblastoma Protein - genetics | Protein Binding | Papillomavirus E7 Proteins - chemistry | Papillomavirus Infections - virology | Human papillomavirus 16 - chemistry | Binding Sites | Human papillomavirus 16 - genetics | Cell Transformation, Viral | Papillomavirus infections | Index Medicus | Human papillomavirus 16/physiology | Papillomavirus Infections/virology | Papillomavirus Infections/metabolism | Papillomavirus E7 Proteins/metabolism | TATA-Box Binding Protein/metabolism | Retinoblastoma Protein/genetics | Virology | Life Sciences | Microbiology and Parasitology | Human health and pathology | TATA-Box Binding Protein/genetics | Papillomavirus E7 Proteins/chemistry | Human papillomavirus 16/chemistry | Papillomavirus E7 Proteins/genetics | Human papillomavirus 16/genetics | Retinoblastoma Protein/metabolism | Papillomavirus Infections/genetics | Cancer
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2013, Volume 132, Issue 1, pp. 198 - 207
Currently, two prophylactic human papillomavirus (HPV) vaccines targeting HPV 16 and 18 have been shown to be highly efficacious for preventing precursor... 
population‐based HPV prevalence | HPV vaccine impact | population-based HPV prevalence | COST-EFFECTIVENESS | NATIONAL-HEALTH | INTRAEPITHELIAL NEOPLASIA | QUADRIVALENT VACCINE | VAGINAL HUMAN-PAPILLOMAVIRUS | ONCOLOGY | GENITAL HUMAN-PAPILLOMAVIRUS | NUTRITION EXAMINATION SURVEY | HPV-VACCINATION | INVASIVE CERVICAL-CANCER | YOUNG-WOMEN | Human papillomavirus 18 - immunology | Prevalence | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 16 - immunology | Mass Vaccination - methods | Incidence | Young Adult | Human papillomavirus 16 - isolation & purification | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Registries | Human papillomavirus 18 - genetics | New Mexico - epidemiology | Papillomavirus Vaccines - administration & dosage | Papillomavirus Infections - epidemiology | Genotype | Human papillomavirus 18 - isolation & purification | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Human papillomavirus 16 - genetics | Measurement | Women | Vaccination | Oncology, Experimental | Research | Nondisclosure agreements | Cobalt | Prevalence studies (Epidemiology) | Papillomaviruses | Prevention | Genetic aspects | Universities and colleges | Health aspects | Cervical cancer | Cancer | Genotype & phenotype | Human papillomavirus | Immunization | Vaccines | Cellular biology | Index Medicus
Journal Article
Pediatrics, ISSN 0031-4005, 09/2014, Volume 134, Issue 3, pp. e657 - e665
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
Summary Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs), cervical intraepithelial neoplasia (CIN) is common, and current... 
Internal Medicine | REGRESSION | MEDICINE, GENERAL & INTERNAL | ELECTROPORATION | METHYLATION | INTEGRATION | IMMUNOTHERAPY | E2 BINDING-SITES | NATURAL-HISTORY | CANCER | BURDEN | EXPRESSION | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2009, Volume 361, Issue 19, pp. 1838 - 1847
Journal Article
JAMA, ISSN 0098-7484, 05/2013, Volume 309, Issue 17, pp. 1793 - 1802
Journal Article
International Journal of Cancer, ISSN 0020-7136, 07/2012, Volume 131, Issue 1, pp. 106 - 116
Journal Article